Multidrug resistent tuberculosis - Nettkurs

This Course is aimed at Enlgish speaking medical practitioners involved in the detection, management and treatment of MDR-TB patients, under the guiding principles of the World Health Organization's Stop TB Strategy.

This Course is intended as an introduction to multidrug-resistant tuberculosis (MDR-TB) management This Course is intended as an introduction to multidrug-resistant tuberculosis (MDR-TB) management, and is aimed at medical practitioners involved in the detection, management and treatment of MDR-TB patients, under the guiding principles of the World Health Organization's Stop TB Strategy. The Course aims to facilitate self-study by medical practitioners of contemporary, evidence-based standards for diagnosis and clinical management of MDR-TB in a variety of geographical, economic and social settings. The course does not include everything you need to know to manage MDR-TB, but serves a good base for understanding the issues.

Programmatic management of drug-resistant TB (PMDT) is now regarded as an essential component of the international approach to TB care, with many countries scaling up these activities. Treatment of drug-resistant TB, including MDR-TB, is complex, expensive, and requires considerable expertise and resources.

The course presupposes essential knowledge of TB transmission, pathogenesis, and the Stop TB Strategy for TB control. In order to control drug-resistant TB worldwide, WHO and its partners recommend the treatment of MDR-TB as a priority in expanded DOTS programmes using The STOP TB Strategy. In order to support countries to meet their commitments, WHO published Guidelines for the programmatic management of drug-resistant tuberculosis 2011 update based on the best evidence and practice currently available. This course is based on WHO guidelines, however, MDR-TB treatment is a programmatic activity, and treatment of patients should preferably be conducted under guidance of National TB Control Programmes and should follow national guidelines.

Disclaimer All reasonable precautions have been taken by the World Medical Association and the New Jersey Medical School (NJMS) Global Tuberculosis Institute. However this course is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Medical Association and the NJMS Global Tuberculosis Institute be liable for damages arising from its use.

As research and experience with MDR-TB progress we do expect that WHO will update its guidelines. We do our best to incorporate changes into the course, however please visit the WHO web page to check for the latest versions of the guidelines. We do our best to incorporate changes into the course, however please visit the WHO web page to check for the latest versions of the guidelines.

The online course was developed by

• The World Medical Association
• The NJMS Global Tuberculosis Institute
• The Norwegian Medical Association
• HELP Design Group